Skip to main content
. 2022 Jun 4;9(6):180. doi: 10.3390/jcdd9060180

Table 1.

Clinical characteristics and CAD pre-test probability calculations.

Total
(n = 1305)
Uncertain
(n = 43; 3.3%)
Appropriate
(n = 496; 38%)
Inappropriate
(n = 766; 56.9%)
p Value
Mean age, years 63.9 ± 9.6 52.6 ± 5.2 62.2 ± 9.3 65.6 ± 9.4 <0.001
Female 416 (31.9) 43 (100.0) 234 (47.2) 139 (18.1) <0.001
BMI 27.2 ± 4.4 27.5 ± 5.8 26.9 ± 4.7 27.3 ± 4.0 0.75
Dyslipidemia
LDL
874 (67.0)
121.1 ± 33.2
23 (53.5)
118.3 ± 49.2
346 (69.8)
135.2 ± 38.0
505 (65.9)
117.7 ± 34.2
0.05
Hypertension
Systolic BP
987 (75.6)
140.3 ± 16.7
28 (65.1)
136.9 ± 19.1
370 (74.6)
140.1 ± 17.1
589 (76.9)
141.3 ± 16.4
0.10
Smoker 543 (41.6) 21 (48.8) 218 (44.0) 304 (39.7) 0.33
Diabetes mellitus
HbA1c
180 (13.8)
5.6 ± 0.6
7 (16.3)
5.8 ± 1.1
61 (12.3)
5.7 ± 0.8
112 (14.6)
5.5 ± 0.7
0.77
Positive FH 429 (32.9) 21 (48.8) 171 (34.5) 237 (30.9) 0.099
Referring sources 0.89
Tertiary 92 (7.0) 4 (9.3) 31 (6.3) 57 (7.4)
Secondary 109 (8.4) 3 (7.0) 43 (8.7) 63 (8.2)
Primary 1104 (84.6) 36 (83.7) 422 (85.1) 646 (84.3)
CCS <0.001
Angina classification
0 533 (40.8) 8 (18.6) 113 (22.8) 412 (53.8)
I 301 (23.1) 28 (65.1) 211 (42.5) 62 (8.1)
II 240 (18.4) 7 (16.3) 148 (29.8) 85 (11.1)
III 117 (8.9) 0 19 (3.8) 98 (12.8)
IV 114 (8.7) 0 5 (1.0) 109 (14.2)
NYHA <0.001
0 25 (1.9) 1 (2.3) 11 (2.2) 13 (1.7)
I 761 (58.3) 18 (41.9) 190 (38.3) 553 (72.2)
II 414 (31.7) 21 (48.8) 256 (51.6) 137 (17.9)
III 92 (7.0) 3 (7.0) 338 (6.7) 56 (7.3)
IV 13 (1.0) 0 6 (1.2) 7 (0.9)
Pre-test probability <0.001
Low 413 (31.6) 43 (100.0) 0 370 (48.3)
Intermediate 496 (38.0) 0 496 (100.0) 0
High 396 (30.3) 0 0 396 (51.7)

Abbreviations: BMI—body mass index, BP—blood pressure, CCS—Canadian Cardiovascular Society scale, FH—family history, LDL—low-density lipoprotein, NYHA—New York Heart Association score. Presented data are mean values and standard deviations for variables approximately normal.